Kushenol W

CAS# 254886-76-5

Kushenol W

Catalog No. BCN3307----Order now to get a substantial discount!

Product Name & Size Price Stock
Kushenol W:5mg Please Inquire In Stock
Kushenol W:10mg Please Inquire In Stock
Kushenol W:20mg Please Inquire In Stock
Kushenol W:50mg Please Inquire In Stock

Quality Control of Kushenol W

Number of papers citing our products

Chemical structure

Kushenol W

3D structure

Chemical Properties of Kushenol W

Cas No. 254886-76-5 SDF Download SDF
PubChem ID 10834013 Appearance Powder
Formula C21H22O7 M.Wt 386.4
Type of Compound Flavonoids Storage Desiccate at -20°C
Solubility Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Chemical Name (2S)-2-(2,4-dihydroxy-5-methoxyphenyl)-5,7-dihydroxy-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one
SMILES CC(=CCC1=C(C=C(C2=C1OC(CC2=O)C3=CC(=C(C=C3O)O)OC)O)O)C
Standard InChIKey IPQQRODECSTJDH-SFHVURJKSA-N
Standard InChI InChI=1S/C21H22O7/c1-10(2)4-5-11-13(22)8-16(25)20-17(26)9-18(28-21(11)20)12-6-19(27-3)15(24)7-14(12)23/h4,6-8,18,22-25H,5,9H2,1-3H3/t18-/m0/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of Kushenol W

The roots of Sophora flavescens Ait.

Biological Activity of Kushenol W

TargetsROS | NF-kB | HSV

Kushenol W Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

Kushenol W Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of Kushenol W

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.588 mL 12.94 mL 25.8799 mL 51.7598 mL 64.6998 mL
5 mM 0.5176 mL 2.588 mL 5.176 mL 10.352 mL 12.94 mL
10 mM 0.2588 mL 1.294 mL 2.588 mL 5.176 mL 6.47 mL
50 mM 0.0518 mL 0.2588 mL 0.5176 mL 1.0352 mL 1.294 mL
100 mM 0.0259 mL 0.1294 mL 0.2588 mL 0.5176 mL 0.647 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on Kushenol W

Nonlinear pulse compression to 43 W GW-class few-cycle pulses at 2 mum wavelength.[Pubmed:29028042]

Opt Lett. 2017 Oct 15;42(20):4179-4182.

High-average power laser sources delivering intense few-cycle pulses in wavelength regions beyond the near infrared are promising tools for driving the next generation of high-flux strong-field experiments. In this work, we report on nonlinear pulse compression to 34.4 muJ-, 2.1-cycle pulses with 1.4 GW peak power at a central wavelength of 1.82 mum and an average power of 43 W. This performance level was enabled by the combination of a high-repetition-rate ultrafast thulium-doped fiber laser system and a gas-filled antiresonant hollow-core fiber.

THE 2017 13(TH) ANNUAL DAVID W. KENNEDY, MD, LECTURE The evolution of outcomes in sinus surgery for chronic rhinosinusitis: past, present, and future.[Pubmed:29028274]

Int Forum Allergy Rhinol. 2017 Dec;7(12):1121-1126.

This is an edited transcript from the 2017 13th Annual David W. Kennedy, MD, Lecture, presented to the American Rhinologic Society during the 63rd Annual Meeting.

Kit (W-sh) Mutation Prevents Cancellous Bone Loss during Calcium Deprivation.[Pubmed:29032463]

Calcif Tissue Int. 2018 Jan;102(1):93-104.

Calcium is essential for normal bone growth and development. Inadequate calcium intake increases the risk of osteoporosis and fractures. Kit ligand/c-Kit signaling plays an important role in regulating bone homeostasis. Mice with c-Kit mutations are osteopenic. The present study aimed to investigate whether impairment of or reduction in c-Kit signaling affects bone turnover during calcium deprivation. Three-week-old male WBB6F1/J-Kit (W) /Kit (W-v) /J (W/W (v) ) mice with c-Kit point mutation, Kit (W-sh) /HNihrJaeBsmJ (W (sh) /W (sh) ) mice with an inversion mutation in the regulatory elements upstream of the c-Kit promoter region, and their wild-type controls (WT) were fed either a normal (0.6% calcium) or a low calcium diet (0.02% calcium) for 3 weeks. muCT analysis indicated that both mutants fed normal calcium diet had significantly decreased cortical thickness and cancellous bone volume compared to WT. The low calcium diet resulted in a comparable reduction in cortical bone volume and cortical thickness in the W/W (v) and W (sh) /W (sh) mice, and their corresponding controls. As expected, the low calcium diet induced cancellous bone loss in the W/W (v) mice. In contrast, W (sh) /W (sh) cancellous bone did not respond to this diet. This c-Kit mutation prevented cancellous bone loss by antagonizing the low calcium diet-induced increase in osteoblast and osteoclast numbers in the W (sh) /W (sh) mice. Gene expression profiling showed that calcium deficiency increased Osx, Ocn, Alp, type I collagen, c-Fms, M-CSF, and RANKL/OPG mRNA expression in controls; however, the W (sh) mutation suppressed these effects. Our findings indicate that although calcium restriction increased bone turnover, leading to osteopenia, the decreased c-Kit expression levels in the W (sh) /W (sh) mice prevented the low calcium diet-induced increase in cancellous bone turnover and bone loss but not the cortical bone loss.

The first anion-exchange membrane fuel cell to exceed 1 W cm(-2) at 70 degrees C with a non-Pt-group (O2) cathode.[Pubmed:29034381]

Chem Commun (Camb). 2017 Aug 22;53(86):11771-11773.

Anion-exchange membrane fuel cells face two challenges: performance and durability. Addressing the first, we demonstrate high performance with both O2 and CO2-free air supplies, even when using a Ag/C cathode. This was enabled by the development of a radiation-grafted anion-exchange membrane that was less than 30 mum thick when hydrated.

Accuracy of W' Recovery Kinetics in High Performance Cyclists-Modeling Intermittent Work Capacity.[Pubmed:29035607]

Int J Sports Physiol Perform. 2018 Jul 1;13(6):724-728.

PURPOSE: With knowledge of an individual's critical power and W', the SKIBA 2 model provides a framework with which to track W' balance during intermittent high-intensity work bouts. There are fears that the time constant controlling the recovery rate of W' (tauW') may require refinement to enable effective use in an elite population. METHODS: Four elite endurance cyclists completed an array of intermittent exercise protocols to volitional exhaustion. Each protocol lasted approximately 3.5-6 min and featured a range of recovery intensities, set in relation to the athlete's critical power (DCP). Using the framework of the SKIBA 2 model, the tauW' values were modified for each protocol to achieve an accurate W' at volitional exhaustion. Modified tauW' values were compared with equivalent SKIBA 2 tauW' values to assess the difference in recovery rates for this population. Plotting modified tauW' values against DCP showed the adjusted relationship between work rate and recovery rate. RESULTS: Comparing modified tauW' values against the SKIBA 2 tauW' values showed a negative bias of 112 (46) s (mean +/- 95% confidence limits), suggesting that athletes recovered W' faster than predicted by SKIBA 2 (P = .0001). The modified tauW'-DCP relationship was best described by a power function: tauW' = 2287.2 x DCP(-0.688) (R(2) = .433). CONCLUSIONS: The current SKIBA 2 model is not appropriate for use in elite cyclists, as it underpredicts the recovery rate of W'. The modified tauW' equation presented will require validation but appears more appropriate for high-performance athletes. Individual tauW' relationships may be necessary to maximize the model's validity.

Keywords:

Kushenol W,254886-76-5,Natural Products, buy Kushenol W , Kushenol W supplier , purchase Kushenol W , Kushenol W cost , Kushenol W manufacturer , order Kushenol W , high purity Kushenol W

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: